Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sanpasitthiprasong Hospital | OTHER_GOV |
| Mahidol Oxford Tropical Medicine Research Unit | OTHER |
Not provided
Not provided
Not provided
Not provided
This is an observational study to evaluate the utility of the latest recommendation to define severity of infection for sepsis patients (sepsis-3), and to identify the aetiology and factors associated with outcome of community-acquired sepsis in Northeast Thailand.
Potential study participants will be adult patients who are presented at the hospital with community-acquired sepsis. Clinical specimens (including blood, urine, sputum, throat swabs and pus or wound swab) will be collected from each participant on admission for culture, PCR and serological tests, and other laboratory tests. Participants' treatment will be closely monitored during the duration of their hospital stay. Blood will be again collected at 72 hours after admission. Participants will be contacted at 28 days after admission to determine clinical outcome by phone interview with standardized script.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adult patients presenting with sepsis | Adult patients, both males and females, presenting with sepsis will be approached for participation in the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Specimens collection | Other | On admission: Blood samples 30.01 mL and other specimens (if available) for culture and other diagnostics tests including sputum, throat swab, urine (midstream urine), and pus which is part of routine practice for patients with sepsis at study site. Day 3: Blood (15 mL) for culture (10 mL) and PCR (5 mL). There will be no blood collection, if patient is discharged before day 3. |
| Measure | Description | Time Frame |
|---|---|---|
| 28-day mortality after admission date | 2.5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Causative organisms of community-acquired sepsis | 2.5 years | |
| Respiration: Blood gas (PaO2 [mmHg]) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) |
Not provided
Inclusion Criteria:
Males and females 18 years old.
Thai nationality.
Required hospitalization as decided by the attending physician
Documented by attending physician that an infection is the primary cause of illness leading to the hospitalization. These can be infections due to any pathogens (bacteria, viruses, fungi and parasites).
qSOFA (quick Sepsis-related Organ Failure Assessment) score ≥ 2 defined as 2 or more of the following:
Exclusion Criteria:
Please note that the following conditions are not exclusion criteria, and patients with the following conditions can be enrolled into the study.
Not provided
Not provided
Not provided
Not provided
Adult patients, both males and females, presenting with sepsis will be approached for participation in the study.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sappasithiprasong Hospital | Ubon Ratchathani | 34000 | Thailand |
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D017714 | Community-Acquired Infections |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Clinical specimens (including blood, urine, sputum, throat swabs and pus or wound swab) will be collected from each participant on admission for culture, PCR and serological tests, and other laboratory tests.
|
| 2.5 years |
| Respiration: Type of oxygen support | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Respiration: FiO2 (% ) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Respiration: SpO2 by pulse oximeter level (%) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Coagulation: Platelet (per μL) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Liver: Total Bilirubin (mg/dL) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Cardiovascular: Mean Arterial Pressure (MAP) at enrolment (mmHg) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Cardiovascular: Dosages (μg/kg/min) of inotropic | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Cardiovascular: Dosages (μg/kg/min) of vasopressor agents | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Central nervous system: Glasgow Coma Score | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Renal: Creatinine (mg/sdL) | Clinical parameters evaluated as according to Sepsis-3 guideline; Sequential Organ Failure Assessment (SOFA) | 2.5 years |
| Hematology | Other laboratory measurement | 2.5 years |
| Blood chemistry | Other laboratory measurement | 2.5 years |
| Causes of sepsis associated with mortality outcome in patients with community-acquired sepsis in northeast Thailand | 2.5 years |
| Sepsis resuscitation associated with mortality outcome in patients with community-acquired sepsis in northeast Thailand | 2.5 years |
| Antimicrobial treatment associated with mortality outcome in patients with community-acquired sepsis in northeast Thailand | 2.5 years |
| Inflammatory associated with mortality outcome in patients with community-acquired sepsis in northeast Thailand | 2.5 years |
| Genetics factors with mortality outcome in patients with community-acquired sepsis in northeast Thailand | 2.5 years |
| Diagnostic tests for infection in community-acquired sepsis in NE Thailand | 2.5 years |
| D013568 |
| Pathological Conditions, Signs and Symptoms |